Skip to main content
. 2017 Apr 4;2017(4):CD011387. doi: 10.1002/14651858.CD011387.pub2
Study characteristics Eligibility criteria
(Insert eligibility criteria for each characteristic as defined in the Protocol)
Yes No Unclear Location in text
(pg & ¶/fig/table)
Type of study Randomized controlled trial        
Participants: adults +18 years
for transabdominal robotic assisted surgery in gynaecology, urology or gastroenterology
         
Types of interventions: TIVA vs inhalational anaesthesia          
Types of outcome measures:
Primary outcomes:
  1. Postoperative pain within 24 hours (as measured by included studies)

  2. PONV within 24 hours (as measured by included studies)


Secondary outcomes:
  1. Adverse effects (as measured by included studies) (e.g. cerebral oedema, stroke, ocular complications)

  2. All‐cause mortality within 90 days

  3. Respiratory complications requiring treatment within 48 hours (as measured by included studies)

  4. Circulatory complications requiring treatment within 48 hours (as measured by included studies)

  5. Cognitive dysfunction (as measured by included studies)

  6. Length of stay in the postoperative ward (as measured by included studies)

  7. Costs (as measured by included studies)

         
INCLUDE EXCLUDE
Reason for exclusion  
Notes: